Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 20152016201720182019
Sales11,84,431,851,800,10
EBITDA-42,9-72,4-105-121-156
Operating profit (EBIT)-43,6-73,9-100-112-151
Pre-Tax Profit (EBT)-56,3-83,2-107-130-157
Net income-39,4-48,9-66,8-77,3-92,9
P/E ratio-11,4-6,93-5,36-5,36-4,02
EPS ( $ )-0,21-0,21-0,30-0,30-0,40
Dividend per Share ( $ )-----
Yield-----
Reference price ( $ )2.4021.4551.608281.608281.60828
Announcement Date04/07/2016
09:05am
04/06/2017
06:33am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt---4,43--
Finance-310275-35,615,8
Operating income (EBITDA)--42,9-72,4-105-121-156
Leverage
(Debt/EBITDA)
----0,04x--
Capital Expenditure-3,463,684,254,754,70
Book Value Per Share (BVPS)--0,76 $-6,00 $-2,30 $-57,8 $
Cash Flow per Share--0,15 $----
Announcement Date01/01/1970
01:00am
04/07/2016
09:05am
04/06/2017
06:33am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 383 M$ -
Entreprise Value (EV) 388 M$ 348 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS)
Capitalization / Revenue 207x 213x
EV / Revenue 210x 193x
EV / EBITDA -3,71x -2,87x
Yield (DPS / Price) - -
Price to book (Price / BVPS) -0,27x -0,70x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) -5 418% -6 246%
operating Leverage (Delta EBIT / Delta Sales) -0,61x -4,50x
Net Margin (Net Profit / Revenue) -3 611% -4 294%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   230% 264%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) -0,04x 0,29x
EPS & Dividend